Page last updated: 2024-08-16

tibolone and Endometrial Hyperplasia

tibolone has been researched along with Endometrial Hyperplasia in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (27.27)	18.2507
2000's	7 (63.64)	29.6817
2010's	1 (9.09)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kane, SC; Quinn, MA	1
Shi, H; Speroff, L; Zang, H	1
Agorastos, T; Bontis, J; Dinas, K; Vaitsi, V; Vakiani, A	1
Agorastos, T; Bontis, J; Constantinidis, T; Dinas, K; Kostopoulou, E; Lolis, D; Paschopoulos, M; Saravelos, H; Vaitsi, V; Vakiani, A; Vavilis, D; Zournatzi-Koiou, V	1
Archer, DF; den Hollander, W; Ferenczy, A; Gallagher, JC; Helmond, FA; Hendrix, S; Rymer, J; Skouby, S; Stathopoulos, V	1
Archer, DF; den Hollander, W; Felix, J; Ferenczy, A; Gallagher, JC; Helmond, FA; Hendrix, S; Rymer, J; Skouby, SO; Stathopoulos, V	1
Sturdee, DW	1
Gillmer, MD; Gray, MD; McEwan, HP; Pyper, RJ; Rollason, TP; von Dadelszen, P; Wright, A	1
Ginsburg, J; Prelevic, GM	1
Coelingh Bennink, HJ; Dören, M; Holzgreve, W; Rübig, A	1
Gorai, I	1

Reviews

2 review(s) available for tibolone and Endometrial Hyperplasia

Article	Year
Endometrial safety and bleeding with HRT: what's new? Climacteric : the journal of the International Menopause Society, 2007, Volume: 10 Suppl 2 Topics: Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Humans; Norpregnenes; Progesterone Congeners; Uterine Hemorrhage; Women's Health	2007
[Drugs in development for the treatment of osteoporosis: Tibolone]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 3 Topics: Animals; Bone Density; Endometrial Hyperplasia; Female; Humans; Norpregnenes; Organ Specificity; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone	2002

Trials

4 trial(s) available for tibolone and Endometrial Hyperplasia

Article	Year
Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia. Maturitas, 2004, Jun-15, Volume: 48, Issue:2 Topics: Adult; Drug Therapy, Combination; Endometrial Hyperplasia; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Injections; Leuprolide; Middle Aged; Norpregnenes; Treatment Outcome	2004
Endometrial effects of tibolone. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:3 Topics: Aged; Carcinoma; Cohort Studies; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Pain; Uterine Hemorrhage	2007
Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women. Fertility and sterility, 2007, Volume: 88, Issue:4 Topics: Aged; Breast; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Female; Humans; Middle Aged; Norpregnenes; Pain; Postmenopause; Vacuum Curettage	2007
Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. Menopause (New York, N.Y.), 1999,Winter, Volume: 6, Issue:4 Topics: Aged; Anabolic Agents; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endosonography; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Norpregnenes; Prospective Studies; Tablets; Uterine Hemorrhage; Vagina	1999

Other Studies

5 other study(ies) available for tibolone and Endometrial Hyperplasia

Article	Year
Complex endometrial hyperplasia in the context of tibolone administration. The Australian & New Zealand journal of obstetrics & gynaecology, 2009, Volume: 49, Issue:3 Topics: Endometrial Hyperplasia; Estrogen Replacement Therapy; Female; Humans; Metrorrhagia; Middle Aged; Norpregnenes	2009
Low-dose hormone therapy in postmenopausal women in China. Climacteric : the journal of the International Menopause Society, 2010, Volume: 13, Issue:6 Topics: Administration, Cutaneous; Adult; Aged; Bone Density; Cardiovascular Diseases; China; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Progesterone; Quinestrol; Randomized Controlled Trials as Topic	2010
Atypical endometrial hyperplasia in an 18-year-old woman. Archives of gynecology and obstetrics, 2003, Volume: 267, Issue:4 Topics: Adolescent; Clomiphene; Diagnosis, Differential; Endometrial Hyperplasia; Female; Humans; Leuprolide; Neoplasm Recurrence, Local; Norpregnenes; Precancerous Conditions; Progestins; Ultrasonography	2003
Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy. British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:2 Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Menopause; Middle Aged; Norpregnenes	1994
Cause of vaginal bleeding in postmenopausal women taking tibolone. Maturitas, 1996, Volume: 24, Issue:1-2 Topics: Aged; Aged, 80 and over; Anabolic Agents; Carcinoma in Situ; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hysteroscopy; Leiomyoma; Middle Aged; Norpregnenes; Polyps; Postmenopause; Time Factors; Ultrasonography, Doppler; Uterine Hemorrhage; Uterine Neoplasms	1996